Slide background
Slide background
Slide background
Slide background

Welcome to TropMed Pharma Consulting

TropMed Pharma Consulting specialises in advising companies, academic institutions, non-governmental organisations (NGOs), and governmental and intergovernmental organisations working on malaria and neglected tropical diseases to help them be more successful.

The challenges in this field are often different from those faced by projects in other areas of medicine. Most projects in this area are carried out in the form of public-private partnerships (PPPs) or product development partnerships (PDPs). The involvement of many different parties from the public and private spheres, with different objectives, skill sets, and expertise can raise challenges that have often not been experienced before by the organisations involved.

Ian Boulton (Managing Director) brings more than 30 years experience in the pharmaceutical industry and over 15 years working in this field to meeting TropMed Pharma Consulting’s Mission. He has been involved in many public-private partnerships and so has experiences (good and bad) to draw on and inform the advice to our clients.

Mission Statement

TropMed Pharma Consulting specialises in advising companies, academic institutions, non-governmental organisations (NGOs), and governmental and intergovernmental organisations working on malaria and neglected tropical diseases to help them be more successful.

About our work

meetingPlanning, R & D, building partnerships and encouraging best practice are key to our success. We work closely with pharmaceutical companies, private and public sector organisations to develop robust strategies in the discovery, development, and deployment of new drugs.
MORE

Our expertise

scientistsIan Boulton has over 30 years' experience working in the pharmaceutical industry, R&D, sales, marketing, business development, strategic planning, & general management. He is recognised as a leading figure in the global effort to control, eliminate, and ultimately eradicate malaria and other tropical diseases.
MORE


Client Recommendations

Prof Win Gutteridge

I have known and worked with Ian Boulton for more 10 years, both while he was leading the Diseases of the Developing World Initiative at GlaxoSmithKline and since he has established TropMed Pharma Consulting. He is one of the world’s leading experts on Discovery, Development, and Access to Medicines in diseases that disproportionately affect the developing world, especially malaria and neglected tropical diseases. He is an outstanding collaborator who has a capacity to analyse complex multifaceted problems into a coherent plan or recommendation having carefully validated it with all stakeholders. He has a fine strategic mind. He is a also first-rate analyst who is able to put together plans and budgets as well as set up systems, giving him a broad capacity useful for any organization whether a start-up, under reorganization, or evaluation. His work for Medicines for Malaria Venture (MMV) was of the highest standard and contributed significantly to our thinking on a key strategic challenge. I regularly turn to Ian to discuss difficult issues. He combines deep pharmaceutical industry experience with intimate knowledge of leading global health organizations (Global Fund, Roll Back Malaria, WHO, etc.), and of institutions and markets in a wide array of geographies, including across the developing world. He is also a fine facilitator and team leader with the ability to bring diverse groups together to consensus on difficult issues while still focused on practical solutions. He is a valued and well-respected colleague. (January 11, 2013)

Board Member - Medicines for Malaria Venture

David Brandling-Bennett

During my 10 years with the Bill and Melinda Gates Foundation, I have had multiple opportunities to work with Ian, especially since joining the RBM Board in 2008.  Both as a RBM Board member himself and subsequently as a consultant, Ian has brought the rigorous thinking and experience of the private sector to a largely public sector oriented partnership.  His knowledge of market dynamics and the vital but often poorly understood role of the private sector was critical to the success of the Affordable Medicines Facility for Malaria (AMFm), which showed clearly that access through the private sector to quality affordable antimalarial drugs could be increased significantly.  With his knowledge and experience in the full range of drug discovery, development, and delivery, Ian can provide essential support to all those seeking to improve access by under-served populations to life-saving commodities, especially by using his skills working with both the private and public sectors. (26 June 2014)

Former Senior Advisor - Malaria, Global Health Division, Bill & Melinda Gates Foundation

Prof Bernard Nahlen

I have worked with Ian, mainly in our work related to the Roll Back Malaria Partnership (RBM), since 2004. Both as a RBM Board member himself and subsequently as a consultant, Ian has brought the rigorous thinking and experience of the private sector to a largely public sector oriented world.  His knowledge of market dynamics and the vital but often poorly understood role of the private sector was critical to the success of the Affordable Medicines Facility for Malaria (AMFm), which showed clearly that access through the private sector to quality affordable antimalarial drugs could be increased significantly. With his knowledge and experience in the full range of drug discovery, development, and delivery, Ian can provide essential support to all those seeking to improve access by under-served populations to life-saving commodities, especially by using his skills working with both the private and public sectors. Ian is very knowledgeable about business sector issues relating to neglected diseases, ranging from manufacturing to distribution, marketing and sales. He is an excellent communicator and strategist, and works well building coalitions within and across sectors. Ian is one of the very few people who can explain complex matters to make these understandable for people who do not have the same level of expertise he has. This and his outstanding capability to engage himself and work constructively in different platforms with changing issues and participants makes him indispensable for engagement with key stakeholders. (05 March 2018)

Director, University of Notre Dame Eck Institute for Global Health (former Deputy Coordinator US President's Malaria Initiative)

Steven C Phillips

I worked directly with Ian as private sector representative on the Board of Roll Back Malaria. Ian is very knowledgeable about business sector issues relating to neglected diseases, ranging from manufacturing to distribution, marketing and sales. He is an excellent communicator and strategist, and works well building coalitions within and across sectors. It was a privilege to work with him over 4 years. (October 26, 2008)

Formerly Senior Fellow, Chatham House & Medical Director - Global Issues and Projects, Exxon Mobil Corporation

Prof Trevor Jones

Ian is one of the leading world experts on Drug Discovery, Development, and Accessibility of Medicines for the Developing World. His expertise across a wide range of infectious diseases that primarily afflict patients in the Developing World is broad-based - ranging from drug design,through clinical development and delivery, to healthcare systems.He has been singularly helpful in advising international organisations and pharmaceutical companies in this field. (January 11, 2013)

President, Sigma Tau Pharmaceuticals Inc.: formerly Director-General, ABPI; Director of R&D, Wellcome Foundation

Prof Sir Brian Greenwood FRS

I have known Ian for about 20 years since we worked together on a Public Private Development Project (PPDP) to develop a new antimalarial drug. At this time, he held a senior position at GlaxoSmithKline and he was instrumental in moving this project forward. Subsequently our paths have crossed on many occasions at different venues, reflecting Ian’s almost unique breadth of knowledge of malaria and neglected tropical diseases, spanning a sound scientific knowledge of these topics, experience of the ways in which large pharmaceutical companies work, experience of working in a PPDP, and of working with non-governmental organisations. His time on the Boards of the Roll Back Malaria Partnership (RBM) and the Malaria Consortium have provided him with experience of working with colleagues from many different backgrounds to support the development of products directed primarily for use in low income countries and then of finding ways to ensure that successful products are deployed widely in the populations where they can have the greatest impact.   During the many times that I have sat on boards or committees with Ian I have always found him knowledgeable, insightful, prepared to work towards a compromise when different views emerge, and  a pleasure to work with. Based on his very broad range of experience, Ian is extremely well qualified to provide advice and support for projects that aim to develop and then deploy drugs or other interventions directed primarily for use in low income countries.  (08 August 2018)

Professor of Clinical Tropical Medicine, London School of Hygiene and Tropical Medicine

Matt Lynch

Ian is a valued and highly-professional consultant and colleague. He worked very hard under a tight timeline and politically charged atmosphere to deliver an extremely well-written and useful document for the Executive Committee of the RBM Board.. This provided the background needed to develop consensus and move a potentially divisive issue towards resolution. Ian has served with me on the RBM Board, and is a strong contributor to the success of the Private Sector Delegation on that Board. (January 23, 2013)

Director of Global Program on Malaria, Center for Communication Programs, Bloomberg School of Public Health, Johns Hopkins University

Prof Steve Ward

I have worked with Ian for almost twenty years, initially when he had a senior role with GSK helping us deliver a new and affordable antimalarial drug as part of the very first PDP in this area. Subsequently I have regularly looked to Ian for support across a broad range of activities important to the Liverpool School of Tropical Medicine (LSTM) that have required his exceptional skills set. Ian is a total professional in everything he does, he has a keen eye for detail and can quickly grasp the most relevant aspects of the most challenging of problems. I have relied on his relaxed pragmatic approach to help facilitate some tricky discussions around global health solutions and practical steps to delivery, in “brain-storming” to bring new ways of thinking to a range of biomedical/health questions and more recently to help our team understand and measure the impact of our research activities in a global health setting.  I can say in all honesty that Ian has never failed to deliver a quality service across the board for the team in LSTM and we will certainly be calling on him again in the future to help us deliver the Schools mission. (19 July 2018).

Deputy Director, Liverpool School of Tropical Medicine

Prof Simon Croft

Ian's knowledge, expertise and contacts in drug development for infectious diseases is of great value to those of us working in the field. His understanding of the way that the private sector, international organisations and academia works provides great support to both strategic and operational aspects of R & D projects and proposals. (07 November 2014)

Professor, London School of Hygiene and Tropical Medicine

Alan Court

I have known Ian for several years, working with him and also sitting on the same Board and in different working groups and task forces of the Roll Back Malaria Board. He is an outstanding colleague who has a capacity to turn multiple and diverse pieces of information into a coherent plan or recommendation having carefully validated with all stakeholders. He is a first-rate analyst who is able to put together plans and budgets as well as set up systems, giving him a diverse capacity useful for any organization whether a start-up, under reorganization or evaluation. This is in addition to his own area of pharmaceuticals where he is also a valuable asset. Ian also writes well, clearly and concisely. A wonderful colleague and a thorough professional. (27 September 2010)

Senior Advisor - UN Secretary General’s Special Envoy for Malaria

MORE RECOMMENDATIONS